Article thumbnail

Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the gamma-Aminobutyric Acid Type A Receptor (GABA(A)R) alpha 6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability

By Daniel Knutson, Revathi Kodali, Branka Divović, Marco Treven, Michael Stephen, Nicolas Zahn, Vladimir Dobričić, Alec Huber, Matheus Meirelles, Ranjit Verma, Laurin Wimmer, Christopher Witzigmann, Leggy Arnold, Lih-Chu Chiou, Margot Ernst, Marko D. Mihovilović, Miroslav Savić, Werner Sieghart and James M. Cook

Abstract

Recent reports indicate that alpha 6/beta 2/3 gamma 2 GABA(A)R selective ligands may be important for the treatment of trigeminal activation-related pain and neuropsychiatric disorders with sensori-motor gating deficits. Based on 3 functionally alpha 6/beta 2/3 gamma 2 GABA(A)R selective pyrazoloquinolinones, 42 novel analogs were synthesized, and their in vitro metabolic stability and cytotoxicity as well as their in vivo pharmacokinetics, basic behavioral pharmacology, and effects on locomotion were investigated. Incorporation of deuterium into the methoxy substituents of the ligands increased their duration of action via improved metabolic stability and bioavailability, while their selectivity for the GABA(A)R a alpha 6 subtype was retained. 8b was identified as the lead compound with a substantially improved pharmacokinetic profile. The ligands allosterically modulated diazepam insensitive alpha 6/beta 2/3 gamma 2 GABA(A)Rs and were functionally silent at diazepam sensitive alpha 6/beta 2/3 gamma 2 GABA(A)Rs, thus no sedation was detected. In addition, these analogs were not cytotoxic, which render them interesting candidates for treatment of CNS disorders mediated by GABA(A)R alpha 6/beta 2/3 gamma 2 subtypes

Publisher: 'American Chemical Society (ACS)'
Year: 2018
DOI identifier: 10.1021/acs.jmedchem.7b01664
OAI identifier: oai:farfar.pharmacy.bg.ac.rs:123456789/3147
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://farfar.pharmacy.bg.ac.r... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.